Turn Medical has released a novel prone positioning device, the Pronova-O2 Automated Prone Therapy System. The Turn Medical Pronova-O2 is the company’s first product launch.
The system provides an effective and efficient way for clinicians to move patients into the prone position and maintain their safety and comfort by easily rotating their position from side to side as needed. Pronova-O2 facilitates three types of positioning therapies: prone therapy, prone therapy with continuous lateral rotation, and supine continuous lateral rotation.
The Turn Medical Pronova-O2 is designed to prevent pressure injuries and to assist in the management of patients experiencing pulmonary distress and/or complications due in part to patient immobility. Such pulmonary distress or complications can arise in immobile patients suffering from pneumonia, sepsis and ventilatory associated events, among others.
Key features include:
- Accommodates patients up to 400 lbs;
- InteliDerm powered skin protection designed to reduce the risk for skin breakdown in key vulnerable areas in the prone position;
- Integrated surface components to protect bedside clinicians from sprains and strains; and
- User interface with efficient workflows to allow for rapid product competency and implementation.
According to the company, substantial research has demonstrated the benefits of prone positioning for critically ill patients with respiratory distress.
“We developed this disruptive technology to address the growing need for a safer and simpler alternative to the labor-intensive manual repositioning of patients by healthcare staff,” commented Tara Psencik, Turn Medical’s CEO. “We believe that we are making significant contributions in the communities where our products and solutions are available as we turn patients toward positive outcomes.”
Pronova-O2 is available for purchase throughout the United States, and for rent in select cities.
Turn Medical Pronova-O2
Go To Source For Respiratory Therapy Coverage
RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.